ETH Zurich
Zurich, 8092, Switzerland
NCT Number: NCT01404533
The overall goal of this research is to develop safe and effective iron interventions that can be administered without production of plasma non-transferrin-bound iron (NTBI: iron in the systemic circulation not bound to the iron-transport protein transferrin). The appearance of plasma non-transferrin-bound iron has been reported in uninfected adult volunteers after oral administration of iron supplements in doses similar to those used in the Pemba trial. This research project will (i) confirm the appearance of plasma non-transferrin-bound iron after administration of an iron supplement like that in the Pemba trial (~1 mg Fe/kg body weight, without food), and then determine the effects on production of plasma non-transferrin-bound iron and on iron absorption measured with stable isotopes (ii) of giving the supplemental iron (~1 mg Fe/kg) with the standard rice meal, and (iii) of giving a lower dose of iron (~0.1 mg Fe/kg) - like that used in home fortification - with the standard rice meal.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Zurich, 8092, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
60 mg Ferrous sulfate
Time frame: 6 time points within 8 hours
Time frame: 6 time points within 8 hours
Swiss Federal Institute of Technology
Other
The Influence of Iron Interventions on Formation of Non-transferrin-bound Iron (NTBI) in Women
Acronym: NTBIwomen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial DetailsNCT05990166
Anemia, Anemia, Hypochromic
Ottawa, Ontario, Canada
View Trial DetailsNCT06773975
Anaemia, Anemia
Accra, Greater Accra Region, Ghana
View Trial DetailsNCT02233764
Iron Deficiencies, Iron Deficiency
Bengaluru, Karnataka, India
View Trial Details